# Trade Mark Journal No.2025/043 24 October 2025

## WO0000001880408 (5,10,45)

Office of origin: United States of America

Date of International Registration:11 September 2025
Date of designation in the UK: 11 September 2025

International priority date claimed: 9 September 2025 (United States of America) (99382166)

Class 5
  Pharmaceutical products for the treatment of cancer; drug delivery systems, namely, drug delivery agents consisting of compounds that facilitate delivery of a range of pharmaceuticals; pharmaceutical preparations, namely, drug delivery systems comprising melphalan hydrochloride for injection for administering high dose chemotherapy to the liver.
Class 10
  Drug delivery systems; double balloon catheter system comprised primarily of catheters.
Class 45
  Providing personal support services for patients and families of patients with liver disorders, namely, financial counseling, help with medical forms and care coordination.

Delcath Systems, Inc.

Representative: Deborah J. Peckham Barclay Damon LLP, 160 Federal Street, Suite 1001, Boston MA 02110, UNITED STATES OF AMERICA